CPMV — Mosaic Immunoengineering Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Mosaic Immunoengineering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 May 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.572	0.226	0.221	0.156	0.115
Net Total Receivables	0.026	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.785	0.269	0.261	0.18	0.142
Net Property, Plant And Equipment	0	—	—	—	—
Long Term Investments
Other Long Term Assets
Total Assets	0.819	0.269	0.261	0.18	0.142
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.183	2.33	3.92	4.73	5.54
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.183	3.07	5.15	6.05	6.93
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	0.636	-2.8	-4.88	-5.87	-6.79
Total Liabilities & Shareholders' Equity	0.819	0.269	0.261	0.18	0.142
Total Common Shares Outstanding
Total Preferred Shares Outstanding